Decreased paediatric antibiotic consumption in France between 2000 and 2010

Scandinavian Journal of Infectious Diseases

Volumn 44, Issue 7, 2012, Pages 495-501

  Dommergues, Marie Aliette ^a   Hentgen, Véronique ^a  

^a CENTRE HOSPITALIER DE VERSAILLES   (France)

Author keywords

Acute otitis media; Antibiotic consumption; France

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BRONCHITIS; CHILD; CHILDHOOD DISEASE; DRUG USE; FRANCE; GENERAL PRACTITIONER; HUMAN; INFANT; LARYNGITIS; OBSERVATIONAL STUDY; OTITIS; PEDIATRICS; PRESCHOOL CHILD; PRESCRIPTION; RHINOPHARYNGITIS; SCHOOL CHILD;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FEMALE; FRANCE; HUMANS; INFANT; INFANT, NEWBORN; MALE; OUTPATIENTS;

EID: 84862572252     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2012.669840     Document Type: Article

References (30)

1. Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005;365: 579-87. (Pubitemid 40247914)
2. Riedel S, Beekmann SE, Heilmann KP, Richter SS, Garciade-Lomas J, Ferech M, et al. Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis 2007;26:485-90. (Pubitemid 47025039)
3. Minist è re de la Santé . Plan national pour pré server l' efficacit é des antibiotiques. France: Minist è re de la Sant é ; 2001. Available at: http://www.sante.gouv.fr/htm/dossiers/ (accessed 16 February 2008).
4. Sipahi OR. Economics of antibiotic resistance. Expert Rev Anti Infect Ther 2008;6:523-39.
5. Bronzwaer S, Lonnroth A, Haigh R. The European Community strategy against antimicrobial resistance. Euro Surveill 2004;9:30-4.
6. Minist è re de la Santé . Plan antibiotiques 2007-2010: propositions du Comit é de suivi pour la deuxi è me phase du Plan pour pr é server l'effi cacit é des antibiotiques (27/11/2007). France: Minist è re de la Sant é ; 2007. Available at: http://www. sante.gouv.fr/htm/dossiers/plan-antibio-2001/bilan- plan-2007.pdf (accessed 17 March 2009).
7. Agence franç aise de s é curit é sanitaire des produits de sant é . Recommandations de l'Afssaps. Antibioth é rapie par voie g é n é rale en pratique courante dans les infections respiratoires: infections respiratoires hautes de l'adulte et de l'enfant (rhinopharyngites, angines aigu ë s, sinusites aigu ë s, otites moyennes aigu ë s). France: Afssaps; 2005. Available at: http:// afssaps.sante.fr/Dossiers-thematiques/Antibiotherapie/ Recommandations2/(offset) /1 (accessed 13 February 2008).
8. Sabuncu E, David J, Bernede-Bauduin C, Pepin S, Leroy M, Boelle PY, et al. Signifi cant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007. PLoS Med 2009;6:e1000084.
9. Leibovitz E. The use of fl uoroquinolones in children. Curr Opin Pediatr 2006;18:64-70.
10. Chalumeau M, Tonnelier S, D' A this P, Treluyer JM, Gendrel D, Breart G, et al. Fluoroquinolone safety in pediatric patients: a prospective, multicenter, comparative cohort study in France. Pediatrics 2003;111:e714-9.
11. Groupe de travail sur les agents anti-infectieux. Recommandations de bonnes pratiques. Antibioth é rapie par voie g é n é -rale en pratique courante dans les infections respiratoires hautes de l'adulte et de l'enfant. France: F é d é ration Fran ç aise d'Infectiologie; 2011. Available at: http://www.infectiologie. com/site/medias/Recos/2011-infections-respir-hautes-recommandations. pdf (accessed 7 February 2011).
12. Keith T, Saxena S, Murray J, Sharland M. Risk-benefi t analysis of restricting antimicrobial prescribing in children: what do we really know? Curr Opin Infect Dis 2010;23:242-8.
13. Klein JO. The burden of otitis media. Vaccine 2000;19: SUPPL. 1:S2-8. (Pubitemid 32121713)
14. Rosenfeld RM, Vertrees JE, Carr J, Cipolle RJ, Uden DL, Giebink GS, et al. Clinical effi cacy of antimicrobial drugs for acute otitis media: metaanalysis of 5400 children from thirty-three randomized trials. J Pediatr 1994;124:355-67. (Pubitemid 24094444)
15. Del Mar C, Glasziou P, Hayem M. Are antibiotics indicated as initial treatment for children with acute otitis media? A meta-analysis. BMJ 1997;314:1526-9. (Pubitemid 27216070)
16. Damoiseaux RA, van Balen FA, Hoes AW, Verheij TJ, de Melker RA. Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ 2000;320:350-4. (Pubitemid 30081675)
17. Haggard M. Poor adherence to antibiotic prescribing guidelines in acute otitis media -obstacles, implications, and possible solutions. Eur J Pediatr 2011;170:323-32.
18. Ganga-Zandzou PS, Fermantel A, Robic C, Pouessel G, Pierre MH, Bourgois B, et al. [Assessment of the management of acute otitis media in children by family practitioners in the North of France]. Presse Med 2009;38:1730-7.
19. Schilder AG, Lok W, Rovers MM. International perspectives on management of acute otitis media: a qualitative review. Int J Pediatr Otorhinolaryngol 2004;68:29-36. (Pubitemid 37550092)
20. European Antimicrobial Resistance Surveillance System (EARSS) annual report 2001. EARSS; 2001. Available at: http://www.rivm.nl/earss/Images/ EARSS%20rapport%20 2001-tcm61 -25026.pdf (accessed 14 April 2009).
21. G uillemot D, Varon E, Bernede C, Weber P, Henriet L, Simon S, et al. Reduction of antibiotic use in the community reduces the rate of colonization with penicillin G-nonsusceptible Streptococcus pneumoniae. Clin Infect Dis 2005;41:930-8. (Pubitemid 41368213)
22. Straetemans M, Sanders EA, Veenhoven RH, Schilder AG, Damoiseaux RA, Zielhuis GA. Pneumococcal vaccines for preventing otitis media. Cochrane Database Syst Rev 2004;(1):CD001480.
23. Pavia M, Bianco A, Nobile CG, Marinelli P, Angelillo IF. Effi cacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis. Pediatrics 2009;123:e1103-10.
24. Zhou F, Shefer A, Kong Y, Nuorti JP. Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004. Pediatrics 2008;121:253-60. (Pubitemid 351198446)
25. Grijalva CG, Nuorti JP, Griffi n MR. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA 2009;302:758-66.
26. Cohen R, Levy C, Bonnet E, Grondin S, Desvignes V, Lecuyer A, et al. Dynamic of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 introduction in France. Vaccine 2010;28:6114-21.
27. Dunais B, Bruno P, Carsenti-Dellamonica H, Touboul P, Dellamonica P, Pradier C. Trends in nasopharyngeal carriage of Streptococcus pneumoniae among children attending daycare centers in southeastern France from 1999 to 2006. Pediatr Infect Dis J 2008;27:1033-5.
28. Prymula R, Schuerman L. 10-valent pneumococcal nontypeable Haemophilus infl uenzae PD conjugate vaccine: Synfl orix. Expert Rev Vaccines 2009;8:1479-500.
29. Dinleyici EC, Yargic ZA. Current knowledge regarding the investigational 13-valent pneumococcal conjugate vaccine. Expert Rev Vaccines 2009;8:977-86.
30. Gulliford M, Latinovic R, Charlton J, Little P, van Staa T, Ashworth M. Selective decrease in consultations and antibiotic prescribing for acute respiratory tract infections in UK primary care up to 2006. J Public Health 2009;31: 512-20.